Home › Industry Awards and Recognition
Drawing from vast research, knowledge, and experience from serving over 350 clients in 35 countries, Xybion offers an integrated CLC & GRC solution that facilitates life sciences companies to achieve higher levels of performance, efficiency, and compliance and lower their total cost of ownership. Xybion offers its solutions to its clients as software, services, or combined solutions. Xybion’s unique integrated GRC solution unifies key areas of compliance such as quality management. Globally, Xybion solutions have been working successfully with the FDA for decades, and we have been the recipient of many awards:
In 2020, Xybion received the Outstanding Service Award from the US FDA National Center of Toxicological Research recognizing Xybion’s Pristima preclinical R&D Solution and Xybion’s outstanding commitment to governance, risk, and compliance that provides excellent support and dedication to modernizing preclinical data management (CDMS).
In 2019, Xybion’s LIMS solution was recognized as one of the Top 10 Best LIMS by Pharma Tech Outlook, a leading resource for pharmaceutical professionals. This award highlights Xybion’s excellence in Digital Lab Management Systems, encompassing LIMS, Electronic Lab Notebooks, Quality Management, and Document Management. This recognition positions Xybion LIMS as a top choice for labs seeking a comprehensive and innovative solution.
In 2012, Xybion received Frost & Sullivan Customer Value Enhancement Award for the valuable accomplishments done in Enterprise Compliance and Quality Management Solutions for the life sciences R&D market.
“Xybion’s solutions—including preclinical, asset management, quality and compliance, risk and governance, and content management—are unparalleled in this space. Xybion’s ability to change in accordance with the market needs and to address the primary challenges of scalability and integration in the best possible manner makes it difficult to match.” -Frost and Sullivan
We use cookies to improve your experience. By continuing to use our site, you accept our use of cookies. Privacy Policy and Terms of Use.
Cookie SettingsAccept